31 related articles for article (PubMed ID: 31492988)
1. The Impact of Omitting 5-FU Bolus From mFOLFOX6 Chemotherapy Regimen on Hematological Adverse Events Among Patients With Metastatic Colorectal Cancer.
Areepium N; Sapapsap B
World J Oncol; 2023 Oct; 14(5):392-400. PubMed ID: 37869236
[TBL] [Abstract][Full Text] [Related]
2. Differences in prognosis and underuse of adjuvant chemotherapy between elderly and non-elderly patients in stage III colorectal cancer.
Shiraishi T; Ogawa H; Shioi I; Ozawa N; Osone K; Okada T; Sohda M; Shirabe K; Saeki H
Ann Gastroenterol Surg; 2023 Jan; 7(1):91-101. PubMed ID: 36643370
[TBL] [Abstract][Full Text] [Related]
3. Management of chemotherapy dose intensity for metastatic colorectal cancer.
Chu X; Xue P; Zhu S
Oncol Lett; 2022 May; 23(5):141. PubMed ID: 35340557
[TBL] [Abstract][Full Text] [Related]
4.
Kang YH; Lee JS; Lee NH; Kim SH; Seo CS; Son CG
Molecules; 2021 Mar; 26(7):. PubMed ID: 33806077
[TBL] [Abstract][Full Text] [Related]
5. Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.
Ueda Y; Enokida T; Okano S; Fujisawa T; Ito K; Tahara M
Front Oncol; 2020; 10():571304. PubMed ID: 33117701
[No Abstract] [Full Text] [Related]
6. Individualized Dosing of Fluoropyrimidine-Based Chemotherapy to Prevent Severe Fluoropyrimidine-Related Toxicity: What Are the Options?
Knikman JE; Gelderblom H; Beijnen JH; Cats A; Guchelaar HJ; Henricks LM
Clin Pharmacol Ther; 2021 Mar; 109(3):591-604. PubMed ID: 33020924
[TBL] [Abstract][Full Text] [Related]
7. A 10-year review of survival among patients with metastatic gastrointestinal cancers: a population-based study.
Abdel-Rahman O
Int J Colorectal Dis; 2020 May; 35(5):911-920. PubMed ID: 32185469
[TBL] [Abstract][Full Text] [Related]
8. A Real-World, Population-Based Analysis of the Outcomes of Colorectal Cancer Patients with Isolated Synchronous Liver or Lung Metastases Treated with Metastasectomy.
Oweira H; Mehrabi A; Reissfelder C; Abdel-Rahman O
World J Surg; 2020 May; 44(5):1604-1611. PubMed ID: 31900570
[TBL] [Abstract][Full Text] [Related]
9. Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis.
Landre T; Uzzan B; Nicolas P; Aparicio T; Zelek L; Mary F; Taleb C; Des Guetz G
Int J Colorectal Dis; 2015 Oct; 30(10):1305-10. PubMed ID: 26099322
[TBL] [Abstract][Full Text] [Related]
10. Differences in efficacy and safety between capecitabine and infusional 5-fluorouracil when combined with irinotecan for the treatment of metastatic colorectal cancer.
Montagnani F; Chiriatti A; Licitra S; Aliberti C; Fiorentini G
Clin Colorectal Cancer; 2010 Oct; 9(4):243-7. PubMed ID: 20920997
[TBL] [Abstract][Full Text] [Related]
11. Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials.
Abdel-Rahman O; Karachiwala H
Int J Colorectal Dis; 2019 Oct; 34(10):1741-1747. PubMed ID: 31492988
[TBL] [Abstract][Full Text] [Related]
12. ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials.
Abdel-Rahman O
Int J Colorectal Dis; 2019 Dec; 34(12):2143-2150. PubMed ID: 31732876
[TBL] [Abstract][Full Text] [Related]
13. Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials.
Abdel-Rahman O
Clin Colorectal Cancer; 2019 Dec; 18(4):e385-e393. PubMed ID: 31378656
[TBL] [Abstract][Full Text] [Related]
14. Impact of Sex on Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer: Pooled Analysis of 5 Randomized Trials.
Abdel-Rahman O
Clin Colorectal Cancer; 2019 Jun; 18(2):110-115.e2. PubMed ID: 30679026
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
